Kevin D. Freeman, Director: Galectin Therapeutics GALT Buy · Filed 24/04/22

Trade details

Type: Insider buy
Amount: $7,450
Shares · price: 2,500 sh · $2.98 a share
Held after: 25,969 sh
Stock: Galectin Therapeutics GALT
Person: Kevin D. FreemanDirector
Trade date: 24/04/22
Filed: 24/04/22
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +10.7%

Galectin Therapeutics trades, last 26 weeks

What else happened in Galectin Therapeutics around then

Filed or reported within 30 days of the trade day · 24/03/23~24/05/22

Kevin D. Freeman's recent trades

Kevin D. FreemanDirector
BuyGalectin Therapeutics
Buy
Galectin Therapeutics
GALT
$19.5K
5,500 sh
$19.5K
Filed 25/12/23
Traded 25/12/23
Kevin D. FreemanDirector
Buy10b5-1 planGalectin Therapeutics
Buy10b5-1 plan
Galectin Therapeutics
GALT
$19.5K
5,500 sh
$19.5K
Filed 25/12/23
Traded 25/12/23
Kevin D. FreemanDirector
Buy10b5-1 planGalectin Therapeutics
Buy10b5-1 plan
Galectin Therapeutics
GALT
$19.5K
5,500 sh
$19.5K
Filed 25/12/23
Traded 25/12/23
Kevin D. FreemanDirector
BuyGalectin Therapeutics
Buy
Galectin Therapeutics
GALT
$14.5K
5,000 sh
$14.5K
Filed 25/07/18
Traded 25/07/17
Kevin D. FreemanDirector
BuyGalectin Therapeutics
Buy
Galectin Therapeutics
GALT
$8,100
10,000 sh
$8,100
Filed 24/12/26
Traded 24/12/24